mhurhangee/ep-ind-claims huggingface dataset:
A system for forwarding a packet, comprising: a Line Card Chassis, LCC, comprising a first LCC's control ether switch unit and a second LCC's control ether switch unit; a first Central Fabric Chassis, CFC, comprising a first CFC's control ether switch unit; and a second CFC comprising a second CFC's control ether switch unit, wherein a control message channel and a protocol packet channel are separately arranged between the first and the second LCC's control ether switch units (31, 32) and the first and the second CFC's control ether switch units (21, 22), the first LCC's control ether switch unit is stacked with the second LCC's control ether switch unit, and the first CFC's control ether switch unit is stacked with the second CFC's control ether switch unit, wherein port information of ports for forming channels are synchronized between the stacked switch units; and the control message channel and the protocol packet channel are determined by judging, via packet negotiations, whether the ports join a Link Aggregation Group, LAG. a Line Card Chassis, LCC, comprising a first LCC's control ether switch unit and a second LCC's control ether switch unit; a first Central Fabric Chassis, CFC, comprising a first CFC's control ether switch unit; and a second CFC comprising a second CFC's control ether switch unit, wherein a control message channel and a protocol packet channel are separately arranged between the first and the second LCC's control ether switch units (31, 32) and the first and the second CFC's control ether switch units (21, 22), the first LCC's control ether switch unit is stacked with the second LCC's control ether switch unit, and the first CFC's control ether switch unit is stacked with the second CFC's control ether switch unit, wherein port information of ports for forming channels are synchronized between the stacked switch units; and the control message channel and the protocol packet channel are determined by judging, via packet negotiations, whether the ports join a Link Aggregation Group, LAG.
A medical device system comprising: an electric field generating circuit configured to generate one or more electric fields; and control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and one or more electrodes disposed on a first stimulation lead to deliver the electric fields to a site of a cancerous tumor within a patient; one or more electrodes disposed on a second stimulation lead to deliver the electric fields to the site of a cancerous tumor within a patient; wherein the first and second stimulation leads are configured to be implanted on or about a duodenum; wherein the control circuitry causes the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz, characterised in that at least one of the first and second stimulation leads comprises one or more thermal shielding pads disposed thereon, wherein the one or more thermal shielding pads are configured to pivot around the first or second stimulation lead. an electric field generating circuit configured to generate one or more electric fields; and control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and one or more electrodes disposed on a first stimulation lead to deliver the electric fields to a site of a cancerous tumor within a patient; one or more electrodes disposed on a second stimulation lead to deliver the electric fields to the site of a cancerous tumor within a patient; wherein the first and second stimulation leads are configured to be implanted on or about a duodenum; wherein the control circuitry causes the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz, characterised in that at least one of the first and second stimulation leads comprises one or more thermal shielding pads disposed thereon, wherein the one or more thermal shielding pads are configured to pivot around the first or second stimulation lead.
Retaining device for at least one battery cell, wherein the retaining device comprises at least two retaining elements (20, 20, 20, 20), wherein each retaining element (20, 20, 20, 20) comprises at least one fastening means (20, 20, 20, 20, (20, 20, 20, 20), characterized in that the at least two retaining elements ((20, 20, 20, 20)) are connected in a mechanically releasable manner by means of the fastening means (20(la), 20, 20, 20, 20(lb), 20, 20, 20), wherein first fastening means (20, 20, 20, 20) have an s-shaped guide rail which corresponds to an inverted form, in particular to a substantially s-shaped groove, of second fastening means (20, 20, 20, 20), wherein the connection between the retaining elements (20, 20, 20, 20) and the battery cell is a positive-locking connection, wherein the retaining device substantially completely surrounds end faces and side faces of the at least one battery cell.
A catheter for measuring a pressure distal of a stenosis, the catheter comprising: a shaft including a housing in a distal portion of the shaft, wherein the housing includes a guidewire lumen; a flexible printed circuit board coupled to the housing; a pressure sensor coupled to the flexible printed circuit board and suspended within the housing; and an aperture configured to allow blood flow into the housing and into contact with the pressure sensor, characterized in that the catheter further comprises a cover coupled to the housing, the cover including a first configuration wherein the cover covers the pressure sensor, wherein the aperture is formed between an inner surface of the cover and an outer surface of the housing. a shaft including a housing in a distal portion of the shaft, wherein the housing includes a guidewire lumen; a flexible printed circuit board coupled to the housing; a pressure sensor coupled to the flexible printed circuit board and suspended within the housing; and an aperture configured to allow blood flow into the housing and into contact with the pressure sensor, characterized in that the catheter further comprises a cover coupled to the housing, the cover including a first configuration wherein the cover covers the pressure sensor, wherein the aperture is formed between an inner surface of the cover and an outer surface of the housing.
A vehicle door fixing apparatus, comprising: a fixed wedge adapted to be assembled on one of a vehicle body panel and a door panel; and a movable wedge adapted to be assembled on the other one of the vehicle body panel and the door panel to be movable in an advancing/receding direction of the door panel relative to the vehicle body panel, wherein the movable wedge is adapted to be assembled on said the other one of the vehicle body panel and the door panel together with one of a base plate of a door lock striker and a door lock assembly that is engageable with a shaft of the door lock striker, the movable wedge includes a strength member that when mounted surrounds a striker-receiving recess provided, for receiving therein the shaft of the door lock striker, at the vehicle body panel or at the door panel any one of which the door lock assembly is assembled on, in a manner that the strength member is opened at a side facing the fixed wedge in the advancing/receding direction, or that surrounds the shaft of the door lock striker in the manner that the strength member is opened at the side facing the fixed wedge in the advancing or receding direction, the movable wedge includes a contact member fixedly attached to the strength member and configured to be in pressure contact with the fixed wedge in a state where the vehicle door is closed, and the strength member includes a rigidity that is higher than a rigidity of the contact member. a fixed wedge adapted to be assembled on one of a vehicle body panel and a door panel; and a movable wedge adapted to be assembled on the other one of the vehicle body panel and the door panel to be movable in an advancing/receding direction of the door panel relative to the vehicle body panel, wherein the movable wedge is adapted to be assembled on said the other one of the vehicle body panel and the door panel together with one of a base plate of a door lock striker and a door lock assembly that is engageable with a shaft of the door lock striker, the movable wedge includes a strength member that when mounted surrounds a striker-receiving recess provided, for receiving therein the shaft of the door lock striker, at the vehicle body panel or at the door panel any one of which the door lock assembly is assembled on, in a manner that the strength member is opened at a side facing the fixed wedge in the advancing/receding direction, or that surrounds the shaft of the door lock striker in the manner that the strength member is opened at the side facing the fixed wedge in the advancing or receding direction, the movable wedge includes a contact member fixedly attached to the strength member and configured to be in pressure contact with the fixed wedge in a state where the vehicle door is closed, and the strength member includes a rigidity that is higher than a rigidity of the contact member.
A system for determining parameter settings for a power generation system, the system comprising: at least one processor; and at least one memory storing computer executable instructions, wherein the at least one memory and the computer executable instructions configured to, with the at least one processor, cause the system to: divide historical power related data of the power generation system into a plurality of power load segments based on typical power load values and the number of the historical power related data; identify feasible parameter ranges for each of the plurality of power load segments, wherein each of the feasible parameter ranges is determined as between a value corresponding to a predetermined lower percentile rank in power related data of respective power load segments and a value corresponding to a predetermined higher percentile rank in power related data of respective power load segments; and determine optimal parameter settings for each of the plurality of power load segments, based on the identified feasible parameters ranges and correlations between system energy efficiency and relative parameters of each of the plurality of power load segments. at least one processor; and at least one memory storing computer executable instructions, wherein the at least one memory and the computer executable instructions configured to, with the at least one processor, cause the system to: divide historical power related data of the power generation system into a plurality of power load segments based on typical power load values and the number of the historical power related data; identify feasible parameter ranges for each of the plurality of power load segments, wherein each of the feasible parameter ranges is determined as between a value corresponding to a predetermined lower percentile rank in power related data of respective power load segments and a value corresponding to a predetermined higher percentile rank in power related data of respective power load segments; and determine optimal parameter settings for each of the plurality of power load segments, based on the identified feasible parameters ranges and correlations between system energy efficiency and relative parameters of each of the plurality of power load segments. divide historical power related data of the power generation system into a plurality of power load segments based on typical power load values and the number of the historical power related data; identify feasible parameter ranges for each of the plurality of power load segments, wherein each of the feasible parameter ranges is determined as between a value corresponding to a predetermined lower percentile rank in power related data of respective power load segments and a value corresponding to a predetermined higher percentile rank in power related data of respective power load segments; and determine optimal parameter settings for each of the plurality of power load segments, based on the identified feasible parameters ranges and correlations between system energy efficiency and relative parameters of each of the plurality of power load segments.
A method for wireless communication in a wireless communication system comprising: determining a first preamble (602; 704; 804; 906) within a first data packet (604; 702; 802; 902) transmitted from a first network node in the wireless communication system, the first preamble (602; 704; 804; 906) including a channel reservation indication configured to indicate a transmission time reservation (606; 706; 806; 908) of channel resources covering the first data packet (604; 702; 802; 902), a second data packet (608; 708; 808; 910) received from a second network node responsive to the first data packet, and a portion of a third data packet (610; 710; 810; 912) transmitted from the first network node subsequent to the transmission of the second data packet; and transmitting the first data packet (604; 702; 802; 902). determining a first preamble (602; 704; 804; 906) within a first data packet (604; 702; 802; 902) transmitted from a first network node in the wireless communication system, the first preamble (602; 704; 804; 906) including a channel reservation indication configured to indicate a transmission time reservation (606; 706; 806; 908) of channel resources covering the first data packet (604; 702; 802; 902), a second data packet (608; 708; 808; 910) received from a second network node responsive to the first data packet, and a portion of a third data packet (610; 710; 810; 912) transmitted from the first network node subsequent to the transmission of the second data packet; and transmitting the first data packet (604; 702; 802; 902).
An assay for identifying a compound for use in the treatment and/or prevention of organ or cell transplant rejection comprising measuring: (a) the binding of phosphatidylinositol-4-kinase IIIβ. (PI4KIIIβ) to a substrate in a sample comprising PI4KIIIβ, the substrate and the compound; and/or (b) the kinase activity of PMKIIIβ in a sample comprising PMKIIIβ and the compound; and comparing the binding of PI4KIIIβ to the substrate in (a) or the kinase activity of PI4KIIIβ in (b) to corresponding values from control samples; and selecting a compound that inhibits the binding of PI4KIIIβ to its substrate in (a), or that inhibits the kinase activity of PI4KIIIβ in (b); whereby the selected compound will be useful in the treatment and/or prevention of organ or cell transplant rejection. (a) the binding of phosphatidylinositol-4-kinase IIIβ. (PI4KIIIβ) to a substrate in a sample comprising PI4KIIIβ, the substrate and the compound; and/or (b) the kinase activity of PMKIIIβ in a sample comprising PMKIIIβ and the compound;
A hydrofluoroether compound represented by the following general formula: wherein, (i) Rf 3 is F, Rf 4 is CF 3, and Rf 1 and Rf 2 are independently perfluoroalkyl groups (a) having 1 to 2 carbon atoms and optionally comprising at least one catenated heteroatom, or (b) that are bonded together to form a ring structure having 4-8 carbon atoms and optionally comprising one or more catenated heteroatoms; or (ii) Rf 3 is CF 3, Rf 4 is F, and Rf 1 and Rf 2 are independently perfluoroalkyl groups (a) having 1 to 8 carbon atoms and optionally comprising at least one catenated heteroatom, or (b) that are bonded together to form a ring structure having 4 to 8 carbon atoms and optionally comprising one or more catenated heteroatoms; and wherein Rfh is a linear, branched, or cyclic alkyl or fluoroalkyl group of from 1 to 10 carbon atoms that may be saturated or unsaturated and optionally comprises one or more catenated heteroatoms. (i) Rf 3 is F, Rf 4 is CF 3, and Rf 1 and Rf 2 are independently perfluoroalkyl groups (a) having 1 to 2 carbon atoms and optionally comprising at least one catenated heteroatom, or (b) that are bonded together to form a ring structure having 4-8 carbon atoms and optionally comprising one or more catenated heteroatoms; or (ii) Rf 3 is CF 3, Rf 4 is F, and Rf 1 and Rf 2 are independently perfluoroalkyl groups (a) having 1 to 8 carbon atoms and optionally comprising at least one catenated heteroatom, or (b) that are bonded together to form a ring structure having 4 to 8 carbon atoms and optionally comprising one or more catenated heteroatoms; and wherein
A lipid composition in the form of a single phase comprising: - component constituting 10 to 80% by weight of the entire composition; being at least one component selected from ceramide represented by formula: and having a D-erythro structure represented by the formula; in a proportion of 95% mole or more of the component: where R 1 is a straight hydrocarbon group having 9 to 17 carbon atoms which may have a hydroxyl group and/or a double bond; R 2 is an acyl group having 14 to 30 carbon atoms which may have a hydroxyl group; and - component being at least one component selected from aliphatic alcohol having 12 to 30 carbon atoms, in an amount 0.5 to 10 times the total amount of the component; the lipid composition being obtainable by dissolving the component and the component through heating at a temperature from 70 to 150°C and cooling, whereby the components and are made into a single phase at 90°C or less. - component constituting 10 to 80% by weight of the entire composition; being at least one component selected from ceramide represented by formula: and having a D-erythro structure represented by the formula; in a proportion of 95% mole or more of the component: where R 1 is a straight hydrocarbon group having 9 to 17 carbon atoms which may have a hydroxyl group and/or a double bond; R 2 is an acyl group having 14 to 30 carbon atoms which may have a hydroxyl group; and where R 1 is a straight hydrocarbon group having 9 to 17 carbon atoms which may have a hydroxyl group and/or a double bond; R 2 is an acyl group having 14 to 30 carbon atoms which may have a hydroxyl group; and - component being at least one component selected from aliphatic alcohol having 12 to 30 carbon atoms, in an amount 0.5 to 10 times the total amount of the component;
A heat exchange element comprising a supply air passage for allowing supply air to pass through and an exhaust air passage for allowing exhaust air to pass through, which are alternately formed between a plurality of heat transfer sheets made of paper and laminated on each other with a predetermined interval; an opposed part formed in a center portion of the heat transfer sheet in the supply air passage and the exhaust air passage, in which the supply air and the exhaust air flow opposite to each other with the heat transfer sheet therebetween; an orthogonal part formed on each end portion of the heat transfer sheet in the supply air passage and the exhaust air passage, in which the supply air and the exhaust air flow orthogonal to each other with the heat transfer sheet therebetween; and a shielding rib being formed in the supply air passage and the exhaust air passage and preventing airflow leakage from regions other than an inlet port and an outlet port of the supply air and the exhaust air; characterized in that: the heat transfer sheet is produced by cutting or punching process from band-like material wound up at the time of sheet-formation; and the heat transfer sheet is disposed so that a direction in which the heat transfer sheet is wound up at the time of sheet formation is perpendicular to a flowing direction in which the supply air and the exhaust air are allowed to pass through in the opposed part. the heat transfer sheet is produced by cutting or punching process from band-like material wound up at the time of sheet-formation; and the heat transfer sheet is disposed so that a direction in which the heat transfer sheet is wound up at the time of sheet formation is perpendicular to a flowing direction in which the supply air and the exhaust air are allowed to pass through in the opposed part.
A method for welding together two metal components (14, 20) to form a large structure suitable for use as an aerospace component, the method comprising the steps of: providing two metal components (14, 20) to be welded together, each component (14, 20) having a length, a width, a height and a surface to be welded (16, 22), characterised in that the surface to be welded (16, 22) of at least one of the metal components (14, 20) includes a feature (18, 24) extending substantially along the length of the component, wherein the feature is a groove (18, 24) creating two distinct contact areas either side of the groove, each contact area having a width (W w) of less than the width of each component (14, 20), and the contact width of the surfaces to be welded of the two components being reduced to less than the width (W w) of each component; and the method further comprises the step of subsequently friction stir welding together the components. providing two metal components (14, 20) to be welded together, each component (14, 20) having a length, a width, a height and a surface to be welded (16, 22), characterised in that the surface to be welded (16, 22) of at least one of the metal components (14, 20) includes a feature (18, 24) extending substantially along the length of the component, wherein the feature is a groove (18, 24) creating two distinct contact areas either side of the groove, each contact area having a width (W w) of less than the width of each component (14, 20), and the contact width of the surfaces to be welded of the two components being reduced to less than the width (W w) of each component; and the method further comprises the step of subsequently friction stir welding together the components.
The improved Etanercept composition stability, comprised of 4%-5% of Etanercept; 0.45%-0.5% of arginine hydrochloride; 0.17%-0.21% of dibasic disodium phosphate heptahydrate; 0.2%-0.25% monosodium monobasic phosphate monohydrate; 0.5%-0.6% sodium chloride; 0.9% -1% sucrose; 0.18%0.2% of mannitol and 92-93% of injectable grade purified water.